These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21058895

  • 21. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H, Strandberg TE, Tikkanen I, Kauhanen P, Lepäntalo M.
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [Abstract] [Full Text] [Related]

  • 22. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 23. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA, Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.
    Am J Cardiol; 2009 Sep 15; 104(6):798-804. PubMed ID: 19733714
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA, Chilmeran SK.
    Saudi Med J; 2007 Dec 15; 28(12):1868-74. PubMed ID: 18060219
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.
    Am J Cardiol; 2007 Nov 15; 100(10):1499-501. PubMed ID: 17996508
    [Abstract] [Full Text] [Related]

  • 26. Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy.
    Zhao W, Zheng XL, Jiang ZN, Liao XB, Zhao SP.
    Int J Cardiol; 2017 Dec 01; 248():355-360. PubMed ID: 28689987
    [Abstract] [Full Text] [Related]

  • 27. [Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study].
    González-Juanatey JR, Cordero A, Vitale GC, González-Timón B, Mazón P, Bertomeu V.
    Rev Esp Cardiol; 2011 Oct 01; 64(10):862-8. PubMed ID: 21835533
    [Abstract] [Full Text] [Related]

  • 28. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents.
    Posadas-Sánchez R, Posadas-Romero C, Zamora-González J, Mendoza-Pérez E, Cardoso-Saldaña G, Yamamoto-Kimura L.
    Metabolism; 2007 Dec 01; 56(12):1666-72. PubMed ID: 17998019
    [Abstract] [Full Text] [Related]

  • 29. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T, Hanefeld M.
    Exp Clin Endocrinol Diabetes; 2004 Feb 01; 112(2):75-9. PubMed ID: 15031770
    [Abstract] [Full Text] [Related]

  • 30. Posttraumatic stress disorder and dyslipidemia: previous research and novel findings from patients with PTSD caused by myocardial infarction.
    Von Känel R, Kraemer B, Saner H, Schmid JP, Abbas CC, Begré S.
    World J Biol Psychiatry; 2010 Mar 01; 11(2):141-7. PubMed ID: 20109110
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
    Zhao S, Wang Y, Mu Y, Yu B, Ye P, Yan X, Li Z, Wei Y, Ambegaonakr BM, Hu D, DYSIS-China Study Investigators.
    Atherosclerosis; 2014 Aug 01; 235(2):463-9. PubMed ID: 24950001
    [Abstract] [Full Text] [Related]

  • 32. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May 01; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 33. Association of dyslipidemia in moderate to severe meibomian gland dysfunction.
    Dao AH, Spindle JD, Harp BA, Jacob A, Chuang AZ, Yee RW.
    Am J Ophthalmol; 2010 Sep 01; 150(3):371-375.e1. PubMed ID: 20619393
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of dyslipidemia and goal attainment after initiating lipid-modifying therapy: a Thai multicenter study.
    Khovidhunkit W, Silaruks S, Chaithiraphan V, Ongphiphadhanakul B, Sritara P, Nimitphong H, Benjanuwattra T, Ambegaonkar BM.
    Angiology; 2012 Oct 01; 63(7):528-34. PubMed ID: 22222187
    [Abstract] [Full Text] [Related]

  • 35. Persistent lipid abnormalities in patients treated with statins: Portuguese results of the Dyslipidemia International Study (DYSIS).
    da Silva PM, Cardoso SM, Investigadores do Estudo DYSIS Portugal.
    Rev Port Cardiol; 2011 Jan 01; 30(1):47-63. PubMed ID: 21425743
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
    Odenigbo CU, Oguejiofor OC, Odenigbo UM, Ibeh CC, Ajaero CN, Odike MA.
    Niger J Clin Pract; 2008 Dec 01; 11(4):330-5. PubMed ID: 19320405
    [Abstract] [Full Text] [Related]

  • 37. Lipid profile changes associated with changing available formulary statins: removing higher potency agents.
    Longyhore DS, Stockton CM, Thomas MR.
    Am J Manag Care; 2009 Jul 01; 15(7):409-14. PubMed ID: 19589008
    [Abstract] [Full Text] [Related]

  • 38. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Jul 01; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 39. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A, Malécot JM, Kerspern H, Nowak E, Carre JL, Mottier D, Le Gal G, Lacut K.
    Atherosclerosis; 2012 Jan 01; 220(1):184-8. PubMed ID: 22035572
    [Abstract] [Full Text] [Related]

  • 40. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D, Keech A, Hunt D, Marschner I, Simes J, Glasziou P, White H, Barter P, Tonkin A, LIPID Study Investigators.
    Eur Heart J; 2004 May 01; 25(9):771-7. PubMed ID: 15120888
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.